Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KIRK B LAMAN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1154329928
CMS profile
278575
Location
CANTON, GA

General Payments · PY2018–2024

$1,251.18

  • Reported across 61 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$359.64

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $359.64 14

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $150.78 11
PY2019 $252.27 11
PY2020 $40.14 2
PY2021 $84.33 4
PY2022 $162.21 9
PY2023 $201.81 10
PY2024 $359.64 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Edwards Lifesciences Corporation $31.38 07/10/2024 Food and Beverage Undisputed 01/23/2026 1138897847 CMS
Esperion Therapeutics, Inc. $23.21 08/28/2024 Food and Beverage Undisputed 01/23/2026 1129443174 CMS
Janssen Pharmaceuticals, Inc $30.04 02/06/2024 Food and Beverage Undisputed 01/23/2026 1077989894 CMS
Merck Sharp & Dohme LLC $22.38 05/06/2024 Food and Beverage Undisputed 01/23/2026 1141857158 CMS
Merck Sharp & Dohme LLC $18.70 10/14/2024 Food and Beverage Undisputed 01/23/2026 1141924179 CMS
Novartis Pharmaceuticals Corporation $34.89 04/29/2024 Food and Beverage Undisputed 01/23/2026 1087084010 CMS
Novartis Pharmaceuticals Corporation $25.27 05/06/2024 Food and Beverage Undisputed 01/23/2026 1087084012 CMS
Novartis Pharmaceuticals Corporation $24.98 06/18/2024 Food and Beverage Undisputed 01/23/2026 1087084014 CMS
Novartis Pharmaceuticals Corporation $24.09 10/01/2024 Food and Beverage Undisputed 01/23/2026 1087084018 CMS
Novartis Pharmaceuticals Corporation $35.19 10/10/2024 Food and Beverage Undisputed 01/23/2026 1087084016 CMS
PFIZER INC. $24.52 12/09/2024 Food and Beverage Undisputed 01/23/2026 1131171913 CMS
Regeneron Healthcare Solutions, Inc. $19.45 07/23/2024 Food and Beverage Undisputed 01/23/2026 1114095239 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $22.32 10/07/2024 Food and Beverage Undisputed 01/23/2026 1080644330 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $23.22 11/11/2024 Food and Beverage Undisputed 01/23/2026 1080644342 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.